List of Tables
Table 1. Global Gabapentin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gabapentin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gabapentin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gabapentin Sales (M Unit) of Key Manufacturers (2019-2024)
Table 5. Global Gabapentin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gabapentin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gabapentin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gabapentin Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gabapentin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gabapentin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gabapentin, Product Type & Application
Table 12. Global Key Manufacturers of Gabapentin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gabapentin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gabapentin Sales by Region (2019-2024) & (M Unit)
Table 18. Global Gabapentin Sales Market Share by Region (2019-2024)
Table 19. Global Gabapentin Sales by Region (2025-2030) & (M Unit)
Table 20. Global Gabapentin Sales Market Share by Region (2025-2030)
Table 21. Global Gabapentin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gabapentin Revenue Market Share by Region (2019-2024)
Table 23. Global Gabapentin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gabapentin Revenue Market Share by Region (2025-2030)
Table 25. North America Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gabapentin Sales by Country (2019-2024) & (M Unit)
Table 27. North America Gabapentin Sales by Country (2025-2030) & (M Unit)
Table 28. North America Gabapentin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gabapentin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gabapentin Sales by Country (2019-2024) & (M Unit)
Table 32. Europe Gabapentin Sales by Country (2025-2030) & (M Unit)
Table 33. Europe Gabapentin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gabapentin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gabapentin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gabapentin Sales by Region (2019-2024) & (M Unit)
Table 37. Asia Pacific Gabapentin Sales by Region (2025-2030) & (M Unit)
Table 38. Asia Pacific Gabapentin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gabapentin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gabapentin Sales by Country (2019-2024) & (M Unit)
Table 42. Latin America Gabapentin Sales by Country (2025-2030) & (M Unit)
Table 43. Latin America Gabapentin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gabapentin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gabapentin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gabapentin Sales by Country (2019-2024) & (M Unit)
Table 47. Middle East & Africa Gabapentin Sales by Country (2025-2030) & (M Unit)
Table 48. Middle East & Africa Gabapentin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gabapentin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gabapentin Sales (M Unit) by Type (2019-2024)
Table 51. Global Gabapentin Sales (M Unit) by Type (2025-2030)
Table 52. Global Gabapentin Sales Market Share by Type (2019-2024)
Table 53. Global Gabapentin Sales Market Share by Type (2025-2030)
Table 54. Global Gabapentin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gabapentin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gabapentin Revenue Market Share by Type (2019-2024)
Table 57. Global Gabapentin Revenue Market Share by Type (2025-2030)
Table 58. Global Gabapentin Price (USD/Unit) by Type (2019-2024)
Table 59. Global Gabapentin Price (USD/Unit) by Type (2025-2030)
Table 60. Global Gabapentin Sales (M Unit) by Application (2019-2024)
Table 61. Global Gabapentin Sales (M Unit) by Application (2025-2030)
Table 62. Global Gabapentin Sales Market Share by Application (2019-2024)
Table 63. Global Gabapentin Sales Market Share by Application (2025-2030)
Table 64. Global Gabapentin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gabapentin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gabapentin Revenue Market Share by Application (2019-2024)
Table 67. Global Gabapentin Revenue Market Share by Application (2025-2030)
Table 68. Global Gabapentin Price (USD/Unit) by Application (2019-2024)
Table 69. Global Gabapentin Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Gabapentin Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Assertio Therapeutics Corporation Information
Table 76. Assertio Therapeutics Description and Business Overview
Table 77. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Assertio Therapeutics Gabapentin Product
Table 79. Assertio Therapeutics Recent Developments/Updates
Table 80. TEVA Corporation Information
Table 81. TEVA Description and Business Overview
Table 82. TEVA Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. TEVA Gabapentin Product
Table 84. TEVA Recent Developments/Updates
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Mylan Gabapentin Product
Table 89. Mylan Recent Developments/Updates
Table 90. Arbor Pharma Corporation Information
Table 91. Arbor Pharma Description and Business Overview
Table 92. Arbor Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Arbor Pharma Gabapentin Product
Table 94. Arbor Pharma Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Novartis Gabapentin Product
Table 99. Novartis Recent Developments/Updates
Table 100. Apotex Corporation Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Apotex Gabapentin Product
Table 104. Apotex Recent Developments/Updates
Table 105. Sun Pharmaceutical Corporation Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Sun Pharmaceutical Gabapentin Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Aurobindo Pharma Corporation Information
Table 111. Aurobindo Pharma Description and Business Overview
Table 112. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Aurobindo Pharma Gabapentin Product
Table 114. Aurobindo Pharma Recent Developments/Updates
Table 115. Intas Corporation Information
Table 116. Intas Description and Business Overview
Table 117. Intas Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Intas Gabapentin Product
Table 119. Intas Recent Developments/Updates
Table 120. Amneal Corporation Information
Table 121. Amneal Description and Business Overview
Table 122. Amneal Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Amneal Gabapentin Product
Table 124. Amneal Recent Developments/Updates
Table 125. Marksans Pharma Corporation Information
Table 126. Marksans Pharma Description and Business Overview
Table 127. Marksans Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Marksans Pharma Gabapentin Product
Table 129. Marksans Pharma Recent Developments/Updates
Table 130. Glenmark Corporation Information
Table 131. Glenmark Description and Business Overview
Table 132. Glenmark Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Glenmark Gabapentin Product
Table 134. Glenmark Recent Developments/Updates
Table 135. Alkem Corporation Information
Table 136. Alkem Description and Business Overview
Table 137. Alkem Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Alkem Gabapentin Product
Table 139. Alkem Recent Developments/Updates
Table 140. Jiangsu Enhua Corporation Information
Table 141. Jiangsu Enhua Description and Business Overview
Table 142. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Jiangsu Enhua Gabapentin Product
Table 144. Jiangsu Enhua Recent Developments/Updates
Table 145. Jiangsu Hengrui Corporation Information
Table 146. Jiangsu Hengrui Description and Business Overview
Table 147. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Jiangsu Hengrui Gabapentin Product
Table 149. Jiangsu Hengrui Recent Developments/Updates
Table 150. Sailike Corporation Information
Table 151. Sailike Description and Business Overview
Table 152. Sailike Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Sailike Gabapentin Product
Table 154. Sailike Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Gabapentin Distributors List
Table 158. Gabapentin Customers List
Table 159. Gabapentin Market Trends
Table 160. Gabapentin Market Drivers
Table 161. Gabapentin Market Challenges
Table 162. Gabapentin Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gabapentin
Figure 2. Global Gabapentin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gabapentin Market Share by Type in 2023 & 2030
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Gabapentin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gabapentin Market Share by Application in 2023 & 2030
Figure 8. Epilepsy
Figure 9. Neuropathic Pain
Figure 10. Restless Legs Syndrome
Figure 11. Others
Figure 12. Global Gabapentin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gabapentin Market Size (2019-2030) & (US$ Million)
Figure 14. Global Gabapentin Sales (2019-2030) & (M Unit)
Figure 15. Global Gabapentin Average Price (USD/Unit) & (2019-2030)
Figure 16. Gabapentin Report Years Considered
Figure 17. Gabapentin Sales Share by Manufacturers in 2023
Figure 18. Global Gabapentin Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Gabapentin Players: Market Share by Revenue in 2023
Figure 20. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Gabapentin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Gabapentin Sales Market Share by Country (2019-2030)
Figure 23. North America Gabapentin Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Gabapentin Sales Market Share by Country (2019-2030)
Figure 27. Europe Gabapentin Revenue Market Share by Country (2019-2030)
Figure 28. Germany Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Gabapentin Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Gabapentin Revenue Market Share by Region (2019-2030)
Figure 35. China Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Gabapentin Sales Market Share by Country (2019-2030)
Figure 46. Latin America Gabapentin Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Gabapentin Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Gabapentin Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Gabapentin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Gabapentin by Type (2019-2030)
Figure 56. Global Revenue Market Share of Gabapentin by Type (2019-2030)
Figure 57. Global Gabapentin Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Gabapentin by Application (2019-2030)
Figure 59. Global Revenue Market Share of Gabapentin by Application (2019-2030)
Figure 60. Global Gabapentin Price (USD/Unit) by Application (2019-2030)
Figure 61. Gabapentin Value Chain
Figure 62. Gabapentin Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed